Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [517]
News [1431]
Articles [66]
Editorials [2]
Conferences [72]
elearning [5]
MyPathway guidance of targeted therapy based on molecular profiles
Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
6 Jun 2016
5 year survival rates for nivolumab-treated metastatic melanoma patients much...
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
6 May 2016
Direct activation of STING in the tumour microenvironment leads to potent and...
Dr Thomas Dubensky - Aduro Biotech, Berkley, USA
Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity ( Dr Thomas Dubensky - Aduro Biotech, Berkley, USA )
4 May 2016
Understanding personalised medicine - the e-learning course
Prof Gordon McVie
Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )
4 May 2016
Pembrolizumab yielded durable responses in patients with advanced Merkel cell...
Dr Paul Nghiem - University of Washington, Seattle, USA
Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )
28 Apr 2016
SPF30 sunscreens delay melanoma incidence in preclinical model
Dr Christin Burd - Ohio State University, Columbus, USA
SPF30 sunscreens delay melanoma incidence in preclinical model ( Dr Christin Burd - Ohio State University, Columbus, USA )
26 Apr 2016
T cells expressing two additional receptors (TETARs) for the use in a multiple...
Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany
T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy ( Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany )
4 Apr 2016
What does the iManageCancer project hope to achieve?
Prof Gordon McVie - ecancer Managing Editor
What does the iManageCancer project hope to achieve? ( Prof Gordon McVie - ecancer Managing Editor )
23 Dec 2015
Drug resistance mechanisms
Dr Floris Groenendijk - Erasmus Medical Center, Rotterdam, Netherlands
Drug resistance mechanisms ( Dr Floris Groenendijk - Erasmus Medical Center, Rotterdam, Netherlands )
22 Dec 2015
Immunotherapy makes patients’ tumours "melt away"
Dr Joshua Brody - Mount Sinai Medical Center, New York, USA
Immunotherapy makes patients’ tumours "melt away" ( Dr Joshua Brody - Mount Sinai Medical Center, New York, USA )
6 Dec 2015
Education and training in the EurocanPlatform project
Dr Angelo Paradiso - National Cancer Research Institute, Bari, Italy
Education and training in the EurocanPlatform project ( Dr Angelo Paradiso - National Cancer Research Institute, Bari, Italy )
4 Dec 2015
Biobanking in the EurocanPlatform project
Dr Peter Riegman - Erasmus University Medical Centre, Rotterdam, The Netherlands
Biobanking in the EurocanPlatform project ( Dr Peter Riegman - Erasmus University Medical Centre, Rotterdam, The Netherlands )
4 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation